Skip to main content
AQST $4.25 +0.00%
AQST logo

AQST · Aquestive Therapeutics, Inc.

Track AQST — free
$4.25 +0.00 (+0.00%) At close · Aug 14
Market Cap
$533.42M
Shares
125.51M
All earnings calls

Earnings call · FY2026 Q2

Aquestive Therapeutics, Inc. Q2 FY2026 Earnings Call

Aquestive Therapeutics, Inc. Q2 FY2026 Earnings Call

Concluded Aug 12, 2026
Aug 12, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $13.82M +38.1% YoY
Diluted EPS -$0.18
Net income -$22.86M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Manufacture and Supply Revenue$11.91M +24.3% YoY
License and Royalty Revenue$1.33M +58% YoY
Co Development and Research Fees$582,000 +54% YoY
Proprietary Product Revenue$0
Full-screen source Call document